Global Financial Private Client, LLC Exelixis, Inc. Transaction History
Global Financial Private Client, LLC
- $267 Billion
- Q4 2024
A detailed history of Global Financial Private Client, LLC transactions in Exelixis, Inc. stock. As of the latest transaction made, Global Financial Private Client, LLC holds 13 shares of EXEL stock, worth $484. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13Holding current value
$484% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding EXEL
# of Institutions
508Shares Held
243MCall Options Held
2.54MPut Options Held
2.29M-
Black Rock Inc. New York, NY33.5MShares$1.25 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA29.3MShares$1.09 Billion0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA25.4MShares$947 Million3.31% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny15.4MShares$572 Million0.63% of portfolio
-
State Street Corp Boston, MA11.4MShares$427 Million0.01% of portfolio
About EXELIXIS, INC.
- Ticker EXEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 321,832,000
- Market Cap $12B
- Description
- Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...